| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Changcheng Lu, Shuhui Qu, Zhangfeng Zhong, Hua Luo, Si San Lei, Hai-Jing Zhong, Huanxing Su, Yitao Wang, Cheong-Meng Chon. The effects of bioactive components from the rhizome of Frontiers in pharmacology. vol 13. 2022-12-19. PMID:36532787. |
pd drugs mainly enhance dopamine levels but cannot prevent or slow down the loss of dopaminergic neurons. |
2022-12-19 |
2023-08-14 |
Not clear |
| Yara T Mohamed, Abeer Salama, Mostafa A Rabie, Mai A Abd El Fatta. Neuroprotective effect of secukinumab against rotenone induced Parkinson's disease in rat model: Involvement of IL-17, HMGB-1/TLR4 axis and BDNF/TrKB cascade. International immunopharmacology. vol 114. 2022-12-17. PMID:36527875. |
furthermore, secukinumab increased striatal tyrosine hydroxylase immunoexpression, the rate limiting step in dopamine biosynthesis, to guard against dopaminergic neuronal loss. |
2022-12-17 |
2023-08-14 |
rat |
| Zamira M Muruzheva, Daniil S Egorov, Margarita T Absalyamova, Dmitrii S Traktirov, Marina N Karpenko, Serguei O Fetisso. Neurotensin-Binding Immunoglobulin G in Patients with Parkinson's Disease. Neuroimmunomodulation. 2022-12-14. PMID:36516809. |
neurotensin (nts) is a 13-amino acid neuropeptide functionally linked with the brain dopaminergic system via expression of the nts peptide or its receptor in dopamine neurons. |
2022-12-14 |
2023-08-14 |
Not clear |
| Ciara Frances Pugh, Brian Thomas DeVree, Solveig Gaarde Schmidt, Claus Juul Lolan. Pharmacological Characterization of Purified Full-Length Dopamine Transporter from Cells. vol 11. issue 23. 2022-12-11. PMID:36497070. |
pharmacological characterization of purified full-length dopamine transporter from the dopamine transporter (dat) is a member of the neurotransmitter:sodium symporter (nss) family, mediating the sodium-driven reuptake of dopamine from the extracellular space thereby terminating dopaminergic neurotransmission. |
2022-12-11 |
2023-08-14 |
Not clear |
| Tatiana Pronina, Ekaterina Pavlova, Liliya Dil'mukhametova, Michael Ugrumo. Development of the Periventricular Nucleus as a Brain Center, Containing Dopaminergic Neurons and Neurons Expressing Individual Enzymes of Dopamine Synthesis. International journal of molecular sciences. vol 23. issue 23. 2022-12-11. PMID:36499006. |
development of the periventricular nucleus as a brain center, containing dopaminergic neurons and neurons expressing individual enzymes of dopamine synthesis. |
2022-12-11 |
2023-08-14 |
rat |
| Tatiana Pronina, Ekaterina Pavlova, Liliya Dil'mukhametova, Michael Ugrumo. Development of the Periventricular Nucleus as a Brain Center, Containing Dopaminergic Neurons and Neurons Expressing Individual Enzymes of Dopamine Synthesis. International journal of molecular sciences. vol 23. issue 23. 2022-12-11. PMID:36499006. |
we have recently shown that the periventricular nucleus (pevn) of adult rats is a "mixed dopaminergic (daergic) center" containing three thousand neurons: daergic neurons and those expressing one of the dopamine (da)-synthesizing enzymes. |
2022-12-11 |
2023-08-14 |
rat |
| Anastasiia Kotliarova, Alexandra V Podturkina, Alla V Pavlova, Daria S Gorina, Anastasiya V Lastovka, Oleg V Ardashov, Artem D Rogachev, Arseniy E Izyurov, Alla B Arefieva, Alexander V Kulikov, Tatyana G Tolstikova, Konstantin P Volcho, Nariman F Salakhutdinov, Yulia Sidorov. A Newly Identified Monoterpenoid-Based Small Molecule Able to Support the Survival of Primary Cultured Dopamine Neurons and Alleviate MPTP-Induced Toxicity Molecules (Basel, Switzerland). vol 27. issue 23. 2022-12-11. PMID:36500381. |
a newly identified monoterpenoid-based small molecule able to support the survival of primary cultured dopamine neurons and alleviate mptp-induced toxicity parkinson's disease (pd) is the most common age-related movement disorder characterized by the progressive loss of nigrostriatal dopaminergic neurons. |
2022-12-11 |
2023-08-14 |
Not clear |
| Lidia Bellés, Chloé Arrondeau, Ginna Urueña-Méndez, Nathalie Ginovar. Concurrent measures of impulsive action and choice are partially related and differentially modulated by dopamine D Pharmacology, biochemistry, and behavior. vol 222. 2022-12-09. PMID:36473517. |
concurrent measures of impulsive action and choice are partially related and differentially modulated by dopamine d impulsivity is a multidimensional construct, but the relationships between its constructs and their respective underlying dopaminergic underpinnings in the general population remain unclear. |
2022-12-09 |
2023-08-14 |
rat |
| Maeri Yamamoto, Toshiya Inad. Positron emission tomography studies in adult patients with attention-deficit/hyperactivity disorder. Japanese journal of radiology. 2022-12-08. PMID:36480104. |
several previous pet studies on the central dopaminergic transmission-related ligands in patients with adhd have shown altered binding of dopamine markers in the basal ganglia. |
2022-12-08 |
2023-08-14 |
Not clear |
| Nace Mikus, Sebastian Korb, Claudia Massaccesi, Christian Gausterer, Irene Graf, Matthäus Willeit, Christoph Eisenegger, Claus Lamm, Giorgia Silani, Christoph Mathy. Effects of dopamine D2/3 and opioid receptor antagonism on the trade-off between model-based and model-free behaviour in healthy volunteers. eLife. vol 11. 2022-12-05. PMID:36468832. |
drugs that target opioid and dopamine receptors are notorious for inducing maladaptive habitual drug consumption; yet, how the opioidergic and dopaminergic neurotransmitter systems contribute to the arbitration between habitual and goal-directed behaviour is poorly understood. |
2022-12-05 |
2023-08-14 |
human |
| Xin Liu, Zhao-Yan Cheng, Yan-Feng Li, Chao Liu, Chen Wang, Gong Xiao-Jian, Ling H. Dopamine D2 receptor agonist Bromocriptine ameliorates Aβ European journal of pharmacology. 2022-12-05. PMID:36470446. |
studies have shown that the dysfunction of the dopaminergic system is related to a variety of pathophysiology of ad, and the expression of dopamine d2 receptor (drd2) in the brains of ad patients and animal models is significantly downregulated, suggesting that drd2 may represent a therapeutic target for ad. |
2022-12-05 |
2023-08-14 |
Not clear |
| P Sivakumar, K B Nagashanmugam, S Priyatharshni, R Lavanya, N Prabhu, S Ponnusam. Review on the interactions between dopamine metabolites and α-Synuclein in causing Parkinson's disease. Neurochemistry international. 2022-12-02. PMID:36460239. |
it is generally believed that dopamine (da) metabolite in dopaminergic (daergic) neurons promotes the aggregation of toxic α-syn oligomers and protofibrils, whereas da inhibits the formation of toxic fibers and even degrades the toxic fibers. |
2022-12-02 |
2023-08-14 |
Not clear |
| Ashley C Parr, Heidi C Riek, Brian C Coe, Giovanna Pari, Mario Masellis, Connie Marras, Douglas P Muno. Genetic Variation in the Dopamine System is Associated with Mixed-Strategy Decision-Making in Parkinson's Patients. The European journal of neuroscience. 2022-12-01. PMID:36453013. |
using a within-subject, multi-center design, patients were examined on and off dopaminergic therapy, and genetic variation was examined via a multilocus genetic profile score representing the additive effects of three single nucleotide polymorphisms (snps) that influence dopamine transmission: rs4680 (comt val |
2022-12-01 |
2023-08-14 |
human |
| Shuai-Nan Zhang, Hong-Mei Li, Qi Liu, Xu-Zhao Li, Wu-de Yang, Ying Zho. Omics combined with network pharmacology reveal the neuroprotective mechanism of Sophora tonkinensis based on the biolabel research pattern: The treatment of Parkinson's disease against oxidative stress and neuroexcitatory toxicity. Biomedical chromatography : BMC. 2022-12-01. PMID:36453605. |
in the pd model, st and its active compounds (caffeic acid and gallic acid) may protect dopaminergic neurons (maximum recovery rate for dopamine: 49.5%) from oxidative stress (prkn, ros, no, etc.) |
2022-12-01 |
2023-08-14 |
mouse |
| Yumin Wang, Shuang Wu, Qiang Li, Weihong Lang, Wenjing Li, Xiaodong Jiang, Zhirong Wan, Huiyan Sun, Hongquan Wan. Salsolinol Induces Parkinson's Disease Through Activating NLRP3-Dependent Pyroptosis and the Neuroprotective Effect of Acteoside. Neurotoxicity research. 2022-12-01. PMID:36454451. |
endogenous neurotoxin 1-methyl-6,7-dihydroxy-1,2,3,4-tetrahydroiso-quinoline (salsolinol, sal) is a dopamine metabolite that is toxic to dopaminergic neurons in vitro and in vivo, and is involved in the pathogenesis of parkinson's disease (pd). |
2022-12-01 |
2023-08-14 |
mouse |
| Yongjun Wang, Zhengjia Pu, Yiran Zhang, Zhaohui Du, Zeming Guo, Qunhua Ba. Exercise training has a protective effect in 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice model with improved neural and intestinal pathology and modified intestinal flora. Behavioural brain research. 2022-12-01. PMID:36455673. |
the results showed in these pd mice, exercise training improved their motility, increased the dopamine (da) content in the striatum, along with promoted the gene expression of tyrosine hydroxylase and brain-derived neurotrophic factor in the striatum, which suggests this exercise training might protect striatal dopaminergic neurons from mptp damage; the results also showed exercise training promoted recovery from ileal pathology, reduced the gene expression of intestinal inflammatory factors, and significantly altered the composition and structure of the intestinal flora in these mice. |
2022-12-01 |
2023-08-14 |
mouse |
| Taejeong Kim, Hyun Jin Kim, Wonseok Choi, Yeong Mi Lee, Jung Hyun Pyo, Junseok Lee, Jeesu Kim, Jihoon Kim, Joung-Hun Kim, Chulhong Kim, Won Jong Ki. Deep brain stimulation by blood-brain-barrier-crossing piezoelectric nanoparticles generating current and nitric oxide under focused ultrasound. Nature biomedical engineering. 2022-12-01. PMID:36456857. |
the release of nitric oxide temporarily disrupted tight junctions in the blood-brain barrier, allowing for the accumulation of the nanoparticles into brain parenchyma, and the piezoelectrically induced output current stimulated the release of dopamine by dopaminergic neuron-like cells. |
2022-12-01 |
2023-08-14 |
mouse |
| Xiaofeng Wang, Naixu Shi, Baiao Wu, Lin Yuan, Jiapeng Chen, Cong Ye, Miao Ha. Bioinformatics analysis of gene expression profile and functional analysis in periodontitis and Parkinson's disease. Frontiers in aging neuroscience. vol 14. 2022-11-28. PMID:36437997. |
the hub genes were then subjected to go enrichment analysis, which revealed that the dopamine biosynthetic process, dopaminergic synapse and dopamine-binding terms, and dopaminergic synapse and serotonergic synapse pathways were primarily where they were expressed. |
2022-11-28 |
2023-08-14 |
Not clear |
| Aleksandra Pytel, Jan Aleksander Beszlej, Monika Biercewicz, Anna Roszmann, Dorota Krówczyńska, Aleksandra Kołtuniu. The Effect of Frailty Syndrome on the Quality of Life of Individuals with Parkinson's Disease: A Pilot Observational and Multicenter Study on the Polish Population. International journal of environmental research and public health. vol 19. issue 22. 2022-11-26. PMID:36429942. |
parkinson's disease (pd) is a neurodegenerative disorder involving decreased dopamine release and atrophy of dopaminergic neurons of the substantia nigra. |
2022-11-26 |
2023-08-14 |
Not clear |
| Laura A Struzyna, Kevin D Browne, Justin C Burrell, Wisberty J Gordián Vélez, Kathryn L Wofford, Hilton M Kaplan, N Sanjeeva Murthy, H Isaac Chen, John E Duda, Rodrigo A España, D Kacy Culle. Axonal Tract Reconstruction Using a Tissue-Engineered Nigrostriatal Pathway in a Rat Model of Parkinson's Disease. International journal of molecular sciences. vol 23. issue 22. 2022-11-26. PMID:36430464. |
immunohistochemistry and fscv established that transplanted te-nsps survived, maintained their axonal tract projections, extended dopaminergic neurites into host tissue, and released dopamine in the striatum. |
2022-11-26 |
2023-08-14 |
rat |